Yutaka Kato Selected Research

4- (N- (1- (2- (4- cyanophenyl)ethyl)- 4- hydroxypiperidin- 4- ylmethyl)- N- methylamino)benzoic acid

10/2006

Pharmacological profiles of the novel analgesic M58996 in rat models of persistent and neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutaka Kato Research Topics

Disease

3	Cataract (Cataracts) 11/2020 - 01/2020
3	Schizophrenia (Dementia Praecox) 08/2016 - 01/2011
3	Asthma (Bronchial Asthma) 06/2006 - 07/2003
2	Endolymphatic Hydrops 05/2022 - 03/2021
2	Neoplasms (Cancer) 03/2022 - 01/2005
2	Macular Degeneration (Age-Related Maculopathy) 11/2020 - 01/2020
2	Neuralgia (Stump Neuralgia) 10/2006 - 10/2005
1	Polyps 11/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Retinal Perforations 01/2020
1	Epiretinal Membrane (Epiretinal Membranes) 01/2020
1	Insulinoma 08/2017
1	Type 2 Diabetes Mellitus (MODY) 08/2017
1	Hypoglycemia (Reactive Hypoglycemia) 08/2017
1	Catalepsy 08/2016
1	Obesity 01/2014
1	Cognitive Dysfunction 01/2011
1	Inflammation (Inflammations) 08/2007
1	Septic Shock (Toxic Shock Syndrome) 08/2007
1	Sepsis (Septicemia) 08/2007
1	Hyperalgesia 10/2006
1	Stroke (Strokes) 01/2006
1	Eosinophilia 12/2005
1	Disease Progression 01/2005
1	Atopic Dermatitis (Atopic Eczema) 01/2005
1	Melanoma (Melanoma, Malignant) 01/2005
1	Splenomegaly 01/2005

Drug/Important Bio-Agent (IBA)

2	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 01/2011
2	Biological ProductsIBA 06/2014 - 01/2011
2	Analgesics (Analgesic Drugs)IBA 10/2006 - 10/2005
2	Immunoglobulin E (IgE)IBA 12/2005 - 01/2005
2	M 50367IBA 01/2005 - 07/2003
1	GadoliniumIBA 05/2022
1	GoldIBA 03/2022
1	Dihydrotachysterol (AT 10)IBA 03/2021
1	CytokinesIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	LectinsIBA 01/2020
1	afliberceptIBA 01/2020
1	Ranibizumab (Lucentis)FDA Link 01/2020
1	AnaphylatoxinsIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Palmitic Acid (Hexadecanoic Acid)IBA 08/2017
1	Glucose (Dextrose)FDA LinkGeneric 08/2017
1	Caspase 3 (Caspase-3)IBA 08/2017
1	Nonesterified Fatty Acids (NEFA)IBA 08/2017
1	Pharmaceutical PreparationsIBA 08/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2017
1	MR1704IBA 08/2017
1	PDM-042IBA 08/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2016
1	morpholineIBA 08/2016
1	Insulin (Novolin)FDA Link 01/2014
1	Toll-Like Receptor 4IBA 08/2007
1	LipopolysaccharidesIBA 08/2007
1	M62812IBA 08/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2007
1	GalactosamineIBA 08/2007
1	Benzoic Acid (Potassium Benzoate)FDA Link 10/2006
1	4- (N- (1- (2- (4- cyanophenyl)ethyl)- 4- hydroxypiperidin- 4- ylmethyl)- N- methylamino)benzoic acidIBA 10/2006
1	Tryptases (Tryptase)IBA 06/2006
1	MetalsIBA 01/2006
1	AcidsIBA 10/2005
1	Interferon-gamma (Interferon, gamma)IBA 01/2005
1	Picryl Chloride (Trinitrochlorobenzene)IBA 01/2005
1	Anti-Allergic Agents (Antiallergic Agents)IBA 07/2003

Therapy/Procedure

1	Radiotherapy 03/2022
1	Vitrectomy 01/2020
1	Intravenous Administration 08/2007
1	Immunomodulation 01/2005